SARS-CoV-2 is a novel betacoronavirus that caused coronavirus disease 2019 and has
resulted in millions of deaths worldwide. Novel coronavirus infections in humans have …

Immunity to previously encountered viruses can alter response to unrelated pathogens. We
reasoned that similar mechanism may also involve SARS-CoV-2 and thereby affect the …

Summary The World Health Organization has declared the ongoing outbreak of COVID-19,
which is caused by a novel coronavirus SARS-CoV-2, a pandemic. There is currently a lack …

To fully decipher the immunogenicity of the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) Spike protein, it is essential to assess which part is highly immunogenic in a …

The prompt rollout of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
mRNA vaccine is facilitating population immunity, which is becoming more dominant than …

Multiple vaccine candidates against SARS-CoV-2 based on viral spike protein are under
development. However, there is limited information on the quality of antibody responses …

Current SARS-CoV-2 vaccines are losing efficacy against emerging variants and may not
protect against future novel coronavirus outbreaks, emphasizing the need for more broadly …

The SARS-CoV-2 proteome shares regions of conservation with endemic human
coronaviruses (CoVs), but it remains unknown to what extent these may be cross …

In the ongoing coronavirus disease 2019 (COVID-19) pandemic, there remain unanswered
questions regarding the nature and significance of the humoral immune response toward …

The ongoing SARS-CoV-2 pandemic demands rapid identification of immunogenic targets
for the design of efficient vaccines and serological detection tools. In this report, using pools …